Latest News and Press Releases
Want to stay updated on the latest news?
-
Net Sales of $536 Million, Ahead of GuidanceNet Income Per Diluted Share of $1.50 Compared to $0.17 Last Year Non-GAAP Net Loss Per Share of ($0.21), Ahead of GuidanceRaises GAAP and Non-GAAP Net...
-
SACRAMENTO, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- The era of speculative digital assets backed only by market hype is rapidly coming to a close as blockchain ecosystems undergo a massive...
-
TORONTO, June 05, 2026 (GLOBE NEWSWIRE) -- McFarlane Lake Mining Limited (CSE: MLM, OTC: MLMLF, FRA: W2Z) (“McFarlane Lake” or the “Company”), a Canadian gold exploration and development company, is...
-
Agreement with Nestlé Health Science provides $25 million payable to Seres in 2026 as a buy-out of potential future VOWST™ net sales-based milestones Restructured lease materially reduces ongoing...
-
Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant
OAK BROOK, Ill., June 05, 2026 (GLOBE NEWSWIRE) -- More than six decades after opening as a small hot dog stand in suburban Chicago, Portillo’s (NASDAQ: PTLO) announced it is headed to Chicago’s...
-
BOSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that, effective June 1, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors...
-
WATERTOWN, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases...
-
Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer Initiation of CLYM116 dosing in IgAN patients in Mabworks Phase 2 study...
-
BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...
-
NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced TelyRx Holdings...